About this trial

Thrombo-embolic venous diseases are represented by deep venous thrombosis and/or pulmonary embolism. In some patients with repeated thrombosis or occurrence of thrombosis in unusual sites, the etiological workup remains negative, which represents a problem for the management of the anticoagulant treatments. Recently, two factors have been identified as important in the physiopathology of hemostasis and coagulation: the presence of clonal hematopoiesis of indetermined potential (CHIP) and the formation of neutrophil extracellular traps (NETs). In this study, these two factors will be studied in patients with repeated venous thrombosis or thrombosis occurring in unusual site.

Eligibility criteria

Qualifiers

Splanchnic venous territory thrombosis or

Cerebral venous thrombosis or

Venous thrombosis of the upper limb or

Pulmonary embolism (1st episode if male, 2nd episode if female) unprovoked or

Disqualifiers

Surgery within the last 3 months preceding the qualifying thrombotic episode

Lower limb fracture with immobilization > 3 days in the last 3 months preceding the qualifying thrombotic episode

Presence of estro-progestational contraception

Pregnancy

Trial design

Treatments tested in this trial

  • Additional blood sampling

Treatment groups

No treatment groups listed

Locations

7
CHU de Bordeaux, Service de Neurologie Bordeaux France
CHU de Bordeaux, Service Gastro-Entérologie Bordeaux France
CHU de Bordeaux, Service Hématologie Biologique Bordeaux France
CHU de Bordeaux, Service Médecine Vasculaire Bordeaux France

Sponsors and collaborators

University Hospital, Bordeaux

Lead sponsor